Keros Therapeutics, Inc.

Keros Therapeutics, Inc. financial statements

Keros Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 243.86M10-K
Net incomeUSD 87.01M10-K
Cash and equivalentsUSD 287.42M10-Q
Total debtUSD 16.88MEODHD

Keros Therapeutics, Inc. financials on 6ix · Keros Therapeutics, Inc. on 6ix